MCKAY UROLOGY LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025
Company registration number SC759489 (Scotland)
PAGES FOR FILING WITH REGISTRAR
MCKAY UROLOGY LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
MCKAY UROLOGY LTD
BALANCE SHEET
AS AT
28 FEBRUARY 2025
28 February 2025
- 1 -
28 February 2025
29 February 2024
Notes
£
£
£
£
Current assets
Debtors
3
1,950
-
0
Cash at bank and in hand
13,451
6,804
15,401
6,804
Creditors: amounts falling due within one year
4
(3,713)
(4,107)
Net current assets
11,688
2,697
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
11,588
2,597
Total equity
11,688
2,697

For the financial year ended 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 13 November 2025 and are signed on its behalf by:
Mr A McKay
Director
Company registration number SC759489 (Scotland)
MCKAY UROLOGY LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025
- 2 -
1
Accounting policies
Company information

McKay Urology Ltd is a private company limited by shares incorporated in Scotland. The registered office is 57 Peel Street, Partickhill, Glasgow, G11 5LX.

1.1
Reporting period

This is the first full year of trade of the company. T he comparative figures represent the period from incorporation to 29 February 2024 and are not therefore directly comparable.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

MCKAY UROLOGY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
1
Accounting policies
(Continued)
- 3 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
3
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
1,950
-
0
MCKAY UROLOGY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 28 FEBRUARY 2025
- 4 -
4
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
2,629
1,137
Other creditors
1,084
2,970
3,713
4,107
5
Related party transactions

'Other creditors' includes £82 (2024: £1,970) due by the company to its directors. This amount is repayable on demand and does not bear interest.

2025-02-28 2024-03-01 false false false 13 November 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mr A McKay I Fullarton SC759489 2024-03-01 2025-02-28 SC759489 2025-02-28 SC759489 2024-02-29 SC759489 core:WithinOneYear 2025-02-28 SC759489 core:WithinOneYear 2024-02-29 SC759489 core:CurrentFinancialInstruments 2025-02-28 SC759489 core:CurrentFinancialInstruments 2024-02-29 SC759489 core:ShareCapital 2025-02-28 SC759489 core:ShareCapital 2024-02-29 SC759489 core:RetainedEarningsAccumulatedLosses 2025-02-28 SC759489 core:RetainedEarningsAccumulatedLosses 2024-02-29 SC759489 bus:Director1 2024-03-01 2025-02-28 SC759489 2023-02-20 2024-02-29 SC759489 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 SC759489 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 SC759489 bus:FRS102 2024-03-01 2025-02-28 SC759489 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 SC759489 bus:Director2 2024-03-01 2025-02-28 SC759489 bus:FullAccounts 2024-03-01 2025-02-28 xbrli:pure xbrli:shares iso4217:GBP